EMA Calls For Zinbryta's ‘Immediate’ Suspension After More Reports of Brain Disorders

Biogen/AbbVie’s Zinbryta is already being withdrawn worldwide, but EMA now wants the MS drug recalled after mounting reports of serious brain disorders.

The EMA has recommended suspending and recalling Zinbryta after 12 reports of serious brain disorders

More from Drug Safety

More from Pink Sheet